[
  {
    "ts": "2025-12-07T05:05:08+00:00",
    "headline": "Is It Too Late To Consider ResMed After Obesity and Sleep Apnea Headlines?",
    "summary": "If you are wondering whether ResMed is still attractive after its strong run, or if the market has already priced in the upside, this article will help you cut through the noise and focus on what the numbers indicate about its value. ResMed shares now trade around $256.55, with returns of 0.3% over the last week, 2.0% over the last month, 12.3% year to date, 7.2% over 1 year, 20.1% over 3 years, and 30.9% over 5 years, hinting at a mix of steady growth and shifting expectations. Recent...",
    "url": "https://finance.yahoo.com/news/too-consider-resmed-obesity-sleep-050508415.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "24626062-88f7-30bb-bdb4-0f79357acaee",
      "content": {
        "id": "24626062-88f7-30bb-bdb4-0f79357acaee",
        "contentType": "STORY",
        "title": "Is It Too Late To Consider ResMed After Obesity and Sleep Apnea Headlines?",
        "description": "",
        "summary": "If you are wondering whether ResMed is still attractive after its strong run, or if the market has already priced in the upside, this article will help you cut through the noise and focus on what the numbers indicate about its value. ResMed shares now trade around $256.55, with returns of 0.3% over the last week, 2.0% over the last month, 12.3% year to date, 7.2% over 1 year, 20.1% over 3 years, and 30.9% over 5 years, hinting at a mix of steady growth and shifting expectations. Recent...",
        "pubDate": "2025-12-07T05:05:08Z",
        "displayTime": "2025-12-07T05:05:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/too-consider-resmed-obesity-sleep-050508415.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/too-consider-resmed-obesity-sleep-050508415.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]